stars 1 stars 2 stars 3

Bioqube Ventures is a global life sciences investment firm with offices in Belgium and the United States. The firm focuses on companies developing first- or best-in-class therapeutics to address major unmet medical needs. Bioqube builds balanced portfolios and supports companies from inception through early clinical milestones. For more information, please visit www.bioqubeventures.com Bioqube Ventures is dedicated to funding therapeutic innovations: - A life sciences venture capital fund – dedicated to advancing exciting science in European and US ecosystems to breakthrough therapies for patients. - A fit-for-purpose dual investment model – besides more classical investments in investment rounds, we have special attention for venture creation projects that require additional experiments prior to creating new ventures. With our in-house factory model we are able to translate exciting science into trailblazing companies. - A hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths. We believe in putting our expertise at work where it matters.

Bioqube Ventures Questions

The Bioqube Ventures annual revenue was $5 million in 2026.

Nico Vandervelpen is the Co-founder and Managing Partner of Bioqube Ventures.

15 people are employed at Bioqube Ventures.

Bioqube Ventures is based in Brussels, Brussels.

The NAICS codes for Bioqube Ventures are [523920, 523, 52392, 5239, 52].

The SIC codes for Bioqube Ventures are [628, 62].

Top Bioqube Ventures Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users